Literature DB >> 3961504

Mechanism of action and monitoring of anticoagulants.

J Hirsh.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 3961504     DOI: 10.1055/s-2007-1003530

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  6 in total

1.  Clotting for the Clinician: An Overview of Thrombosis and Antithrombotic Therapy.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  Antithrombin III activity (residual thrombin activity) in plasma from non-medicated or heparinized horses.

Authors:  B J Darien; J Potempa; J N Moore; J Travis
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

Review 3.  Risk-benefit assessment of anticoagulant therapy.

Authors:  R Harrington; J Ansell
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

4.  Stabilized infective endocarditis and altered heparin responsiveness during cardiopulmonary bypass.

Authors:  Sungwon Na; Jae Kwang Shim; Duk-Hee Chun; Dae Hee Kim; Seong Wook Hong; Young-Lan Kwak
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

5.  Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic.

Authors:  J P Pell; B McIver; P Stuart; D N Malone; J Alcock
Journal:  Br J Gen Pract       Date:  1993-04       Impact factor: 5.386

6.  Outpatient management of venous thromboembolic disease with subcutaneous lepirudin: a case report.

Authors:  Susan M Begelman; Steven R Deitcher
Journal:  J Thromb Thrombolysis       Date:  2002-06       Impact factor: 2.300

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.